(lp0
S'AMAG Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 22 Equities.com - 9 hours ago AMAG Pharmaceuticals Inc.  traded on unusually high volume on Mar. 22, as the stock gained 1.64% to close at $21.75. On the day, AMAG Pharmaceuticals Inc. saw 1.49 million shares trade hands on 9,647 trades. Considering that the stock&nbsp;...AMAG Pharmaceuticals, Inc.  Yearly Sales Projections At $173.528 - Equities Focus'
p1
aS'Traders Secrets on AMAG Pharmaceuticals, Inc. , Vitamin Shoppe, Inc.  StockNewsJournal - 20 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p2
aS"Sell-Side Analyst's Predictions: AMAG Pharmaceuticals, Inc. , Nasdaq ... The USA Commerce - 18 hours ago Presently AMAG Pharmaceuticals, Inc.  stock have an ABR of 2.78. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.AMAG Pharmaceuticals, Inc. : A Detailed Look at its Institutional Ownership - Post AnalystTraders Focused Stock: AMAG Pharmaceuticals, Inc.  - Is stories"
p3
aS'AMAG Pharmaceuticals Inc.  Plunges 5.52% on March 21 Equities.com - Mar 21, 2017 AMAG Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 5.52%, or a loss of $-1.25 per share, to close at $21.40.'
p4
aS'AMAG Pharmaceuticals Inc Risk Points versus Health Care CML News - Mar 21, 2017 This is a scatter plot analysis of the critical risk points from the option market for AMAG Pharmaceuticals Inc  compared to its own past and the Health Care ETF.'
p5
aS"AMAG Announces Management Changes and New Commercial Appointments GlobeNewswire  - Mar 6, 2017 WALTHAM, Mass., March 06, 2017  -- AMAG Pharmaceuticals, Inc.  today announced changes to the company's executive and commercial leadership teams, including that Frank Thomas, president and chief operating&nbsp;...Significant Buzzer of Recent Trading Period: AMAG Pharmaceuticals, Inc ... - Is storiesAMAG Pharma  Says COO Frank Thomas to Depart - StreetInsider.com"
p6
aS'Technical Roundup On Two Stocks  BioTime, Inc. , AMAG Pharmaceuticals ... Post Analyst - Mar 21, 2017 BioTime, Inc. has a consensus buy rating from 3 Wall Street analysts, and the number of shares currently sold short amount to at least 5.35% of shares outstanding.'
p7
aS'AMAG Pharmaceuticals, Inc.  Files An 8-K Departure of Directors ... Market Exclusive - Mar 6, 2017 AMAG Pharmaceuticals, Inc.  Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.'
p8
aS'Technical Clues For AMAG Pharmaceuticals, Inc.  Investors USA Commerce Daily - Mar 20, 2017 With all other things going on, AMAG Pharmaceuticals, Inc.  has been on a free fall - declining -34.81 percent in just three months.'
p9
aS'Stock Returns: BioSpecifics Technologies Corp.  is Beating AMAG ... CML News - Mar 20, 2017 This is a snapshot to compare the stock returns for AMAG Pharmaceuticals Inc  versus BioSpecifics Technologies Corp.'
p10
a.